Impact Biomedical annual operating margin
2022
2025
Impact Biomedical Operating Margin Growth & History (IBO)
Impact Biomedical's operating margin was −13,381.25% for fiscal 2025.
View full Impact Biomedical company overviewImpact Biomedical annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −13,381.25% | — |
| 2022 | 2022-12-31 | −6,808.00% | — |
Impact Biomedical quarterly operating margin
Q2.22
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −23,400.00% | −6928.57 pp |
| Q1 2026 | 2026-03-31 | −32,700.00% | — |
| Q4 2025 | 2025-12-31 | −16,728.57% | — |
| Q3 2025 | 2025-09-30 | −5,266.67% | — |
| Q2 2025 | 2025-06-30 | −16,471.43% | — |
| Q2 2022 | 2022-06-30 | −1,500.00% | — |
Impact Biomedical operating margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Impact Biomedical's operating margin decreased from −6,808.00% to −13,381.25%, a change of −6573.25 percentage points. The latest reported quarter, Q2 2026, shows −23,400.00%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Impact Biomedical source filings ↗